National Health Investors’ (NHI) Hold Rating Reiterated at Mizuho
National Health Investors, Inc. (NYSE:NHI)‘s stock had its “hold” rating reiterated by equities research analysts at Mizuho in a research note issued to investors on Wednesday. They currently have a $82.00 target price on the real estate investment trust’s stock. Mizuho’s price target would indicate a potential upside of 5.28% from the company’s current price.
NHI has been the topic of several other reports. Zacks Investment Research cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. BidaskClub raised shares of National Health Investors from a “sell” rating to a “hold” rating in a report on Thursday, August 17th. Stifel Nicolaus reiterated a “buy” rating and issued a $82.00 target price on shares of National Health Investors in a research note on Wednesday. Finally, KeyCorp reiterated a “hold” rating on shares of National Health Investors in a research note on Sunday, September 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. National Health Investors currently has an average rating of “Hold” and an average target price of $80.20.
National Health Investors (NYSE:NHI) traded up 0.03% during mid-day trading on Wednesday, reaching $77.91. The company had a trading volume of 37,382 shares. The company’s 50 day moving average is $79.16 and its 200 day moving average is $76.54. The stock has a market capitalization of $3.19 billion, a price-to-earnings ratio of 20.01 and a beta of 0.56. National Health Investors has a 52-week low of $66.31 and a 52-week high of $81.21.
National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.29 by ($0.36). The firm had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The company’s revenue for the quarter was up 14.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.22 EPS. Equities analysts predict that National Health Investors will post $3.85 earnings per share for the current year.
WARNING: This article was originally published by Marea Informative and is owned by of Marea Informative. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at http://www.mareainformativa.com/national-health-investors-nhi-hold-rating-reiterated-at-mizuho/115552/.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total transaction of $159,600.00. Following the sale, the insider now owns 21,228 shares of the company’s stock, valued at approximately $1,693,994.40. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 5.19% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Carroll Financial Associates Inc. bought a new position in shares of National Health Investors in the second quarter worth about $158,000. Quantbot Technologies LP acquired a new position in shares of National Health Investors during the first quarter worth approximately $201,000. Yorktown Management & Research Co Inc bought a new stake in shares of National Health Investors during the second quarter valued at approximately $214,000. Allegis Investment Advisors LLC bought a new stake in shares of National Health Investors during the second quarter valued at approximately $216,000. Finally, Profund Advisors LLC grew its stake in shares of National Health Investors by 4.3% during the second quarter. Profund Advisors LLC now owns 3,126 shares of the real estate investment trust’s stock valued at $248,000 after purchasing an additional 130 shares during the last quarter. 70.67% of the stock is owned by institutional investors.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.